慢性乙型肝炎环状RNA表达谱的鉴定与分析

周明纱, 范捷, 刘兴, 谌丽娟, 罗佳, 李山, 周莉

PDF(5664 KB)
PDF(5664 KB)
重庆医科大学学报 ›› 2024, Vol. 49 ›› Issue (09) : 1193-1200. DOI: 10.13406/j.cnki.cyxb.003582
临床研究

慢性乙型肝炎环状RNA表达谱的鉴定与分析

作者信息 +

Identification and analysis of circular RNA expression profiles in chronic hepatitis B

Author information +
History +

摘要

目的 分析慢性乙型肝炎(chronic hepatitis B,CHB)患者与健康对照人群的外周血单核细胞(peripheral blood mononuclear cells,PBMCs)中环状RNA(circular RNA,circRNA)表达谱,筛选验证差异表达的circRNA,并研究差异表达circRNA的特征、通路及下游基因。 方法 利用高通量芯片技术鉴定CHB患者和健康对照组中异常表达circRNA。随后对差异circRNA来源基因进行基因本体论和京都基因百科全书富集分析。基于竞争性内源RNA理论,利用多个数据库预测差异circRNA结合的微小RNA(microRNA,miRNA)和miRNA靶mRNA,并构建circRNA-miRNA-mRNA调控网络。最后利用实时荧光定量PCR(quantitative real-time PCR,qRT-PCR)对芯片结果进行验证。 结果 与健康对照组相比,CHB患者PBMCs中存在321个表达上调和549个表达下调的circRNAs。大多数差异表达circRNAs来源于外显子剪切,主要分布于1号和2号染色体。生物信息学分析表明差异circRNAs的来源基因主要参与免疫、炎症反应及疾病相关通路。circRNA-miRNA-mRNA调控网络包括11个circRNAs、17个miRNAs和212个mRNAs。qRT-PCR结果显示circRNA表达趋势与芯片结果一致。与健康对照组比较,hsa_circ_0018744表达在CHB患者组中明显上调(F=4.382,P<0.01),hsa_circ_0085744表达明显下调(F=4.906,P<0.01)。 结论 与健康对照组相比,CHB患者PBMCs中存在差异表达的circRNAs。进一步功能分析表明,这些差异表达circRNAs可以通过某些通路参与CHB发生发展。

Abstract

Objective To analyze the expression profiles of circular RNAs(circRNAs) in peripheral blood mononuclear cells (PBMCs) in patients with chronic hepatitis B(CHB) and healthy controls,select and validate differentially expressed circRNAs,and study the characteristics,pathways,and downstream genes of differentially expressed circRNAs. Methods We identified differentially expressed circRNAs between patients with CHB and controls using high-throughput microarray technology; performed Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses on the origin genes of the differentially expressed circRNAs; based on the competing endogenous RNA hypothesis,predicted the target micro RNAs(miRNAs) of the differentially expressed circRNAs and the target messenger RNAs(mRNAs) of the miRNAs using multiple databases to construct a circRNA-miRNA-mRNA regulatory network;and finally,validated the microarray results using quantitative real-time PCR(qRT-PCR). Results A total of 321 upregulated circRNAs and 549 downregulated circRNAs were found in PBMCs of patients with CHB compared with healthy controls. Most of the differentially expressed circRNAs were derived from exon splicing,and were mainly distributed on chromosomes 1 and 2. The enrichment analyses demonstrated that the origin genes of the differentially expressed circRNAs were mainly involved in immune,inflammatory response,and disease-related pathways. The established circRNA-miRNA-mRNA regulatory network consisted of 11 circRNAs,17 miRNAs,and 212 mRNAs. The qRT-PCR results demonstrated that circRNA expression trends were consistent with the microarray results. Notably,in the CHB group,hsa_circ_0018744 was significantly upregulated(F=4.382,P<0.01),and hsa_circ_0085744 was significantly downregulated(F=4.906,P<0.01),as compared with healthy controls. Conclusion The identified differentially expressed circRNAs in PBMCs between patients with CHB and healthy controls may play a role in the development and progression of CHB through certain pathways.

关键词

慢性乙型肝炎 / 环状RNA / 高通量芯片 / 实时荧光定量PCR

Key words

chronic hepatitis B / circular RNA / high-throughput microarray / quantitative real-time PCR

中图分类号

R183.9

引用本文

导出引用
周明纱 , 范捷 , 刘兴 , . 慢性乙型肝炎环状RNA表达谱的鉴定与分析. 重庆医科大学学报. 2024, 49(09): 1193-1200 https://doi.org/10.13406/j.cnki.cyxb.003582
Zhou Mingsha, Fan Jie, Liu Xing, et al. Identification and analysis of circular RNA expression profiles in chronic hepatitis B[J]. Journal of Chongqing Medical University. 2024, 49(09): 1193-1200 https://doi.org/10.13406/j.cnki.cyxb.003582

参考文献

1
Ren H. The experience of management of chronic hepatitis B in China[J]. J Viral Hepat201724(s1):4-5.
2
Soriano V Young B Reau N. Report from the international conference on viral hepatitis - 2017[J]. AIDS Rev201820(1):58-70.
3
Liu J Liang WN Jing WZ,et al. Countdown to 2030:eliminating hepatitis B disease,China[J]. Bull World Health Organ201997(3):230-238.
4
Su S Wong WC Zou ZR,et al. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China:an economic evaluation[J]. Lancet Glob Health202210(2):e278-e287.
5
Akbar SMF Yoshida O Hiasa Y. Immune therapies against chronic hepatitis B[J]. J Gastroenterol202257(8):517-528.
6
Yang ZJ Sun BZ Xiang JC,et al. Role of epigenetic modification in interferon treatment of hepatitis B virus infection[J]. Front Immunol202213:1018053.
7
Lau G Yu ML Wong G,et al. APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy[J]. Hepatol Int202115(5):1031-1048.
8
Memczak S Jens M Elefsinioti A,et al. Circular RNAs are a large class of animal RNAs with regulatory potency[J]. Nature2013495(7441):333-338.
9
Hsiao KY Sun HS Tsai SJ. Circular RNA - New member of noncoding RNA with novel functions[J]. Exp Biol Med2017242(11):1136-1141.
10
Zhou TC Li X Chen LJ,et al. Differential expression profile of hepatic circular RNAs in chronic hepatitis B[J]. J Viral Hepat201825(11):1341-1351.
11
Chen L Sun ZG Xu H,et al. Emerging roles of circular RNAs in thyroid cancer[J]. Exp Cell Res2021404(2):112626.
12
He W Zhu XY Tang XY,et al. Circ_0027089 regulates NACC1 by targeting miR-136-5p to aggravate the development of hepatitis B virus-related hepatocellular carcinoma[J]. Anticancer Drugs202233(1):e336-e348.
13
Huang XY Huang ZL Xu YH,et al. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma[J]. Sci Rep20177(1):5428.
14
Panda AC. Circular RNAs act as miRNA sponges[J]. Adv Exp Med Biol20181087:67-79.
15
Si T Ning XJ Chen HH,et al. ANTXR1 as a potential prognostic biomarker for hepatitis B virus-related hepatocellular carcinoma identified by a weighted gene correlation network analysis[J]. J Gastrointest Oncol202112(6):3079-3092.
16
Marotel M Villard M Drouillard A,et al. Peripheral natural killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion[J]. Elife202110:e60095.
17
Zheng YY Li J Johnson DL,et al. Regulation of hepatitis B virus replication by the ras-mitogen-activated protein kinase signaling pathway[J]. J Virol200377(14):7707-7712.
18
Xie XY Lv HR Liu CX,et al. HBeAg mediates inflammatory functions of macrophages by TLR2 contributing to hepatic fibrosis[J]. BMC Med202119(1):247.
19
Chen WJ Bian HJ Xie XY,et al. Negative feedback loop of ERK/CREB/miR-212-3p inhibits HBeAg-induced macrophage activation[J]. J Cell Mol Med202024(18):10935-10945.
20
Yu FJ Chen BC Fan XF,et al. Epigenetically-regulated microRNA-9-5p suppresses the activation of hepatic stellate cells via TGFBR1 and TGFBR2[J]. Cell Physiol Biochem201743(6):2242-2252.
21
Guo YH Kang W Lei XY,et al. Hepatitis B viral core protein disrupts human host gene expression by binding to promoter regions[J]. BMC Genomics201213:563.
22
Mao RC Dong MH Shen ZL,et al. RNA helicase DDX17 inhibits hepatitis B virus replication by blocking viral pregenomic RNA encapsidation[J]. J Virol202195(19):e0044421.
23
李德瑶,陆丹娟,曲晨箫,等. 乙型肝炎病毒RNA的转录后调控机制及抗病毒策略[J]. 中华肝脏病杂志202432(5):474-480.
Li DY Lu DJ Qu CX,et al. Post-transcriptional regulation mechanism and antiviral strategy of hepatitis B virus RNA[J]. Chin J Hepatol202432(5):474-480.
24
Kong Z Lu YL Yang Y,et al. m6A-mediated biogenesis of circDDIT4 inhibits prostate cancer progression by sequestrating ELAVL1/HuR[J]. Mol Cancer Res202321(12):1342-1355.
25
Kunadirek P Ariyachet C Sriphoosanaphan S,et al. Identification of BHLHE40 expression in peripheral blood mononuclear cells as a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma[J]. Sci Rep202111(1):11201.
26
El-Kafrawy SA El-Daly MM Bajrai LH,et al. Genomic profiling and network-level understanding uncover the potential genes and the pathways in hepatocellular carcinoma[J]. Front Genet202213:880440.

基金

重庆市渝中区自然科学基金资助项目(20210139)
重庆医科大学未来医学青年创新计划资助项目(W0177)
重庆市自然科学基金资助项目(CSTB2024NSCQ-MSX0169)

评论

PDF(5664 KB)

Accesses

Citation

Detail

段落导航
相关文章

/